Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAB-Card: Bronchodilators and Cardiac Autonomic Control in COPD
NCT02872090Phase 4Completed
- Sponsor
- CHU de Besançon
- Start
- Mar 2016
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indacaterol, glycopyrrolate metered dose inhaler, tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by CHU de Besançon. Started Mar 2016; status: completed.
02
Drugs
indacaterolglycopyrrolate metered dose inhalertiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02872090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872090.